MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER

被引:0
|
作者
Aoki, Maria
Naiki, Taku
Morikawa, Toshiharu
Isobe, Teruki
Gonda, Masakazu
Tomiyama, Nami
Shimizu, Nobuhiko
Noda, Yusuke
Nagai, Takashi
Banno, Rika
Nozaki, Satoshi
Etani, Toshiki
Ando, Ryosuke
Kawai, Noriyasu
Yasui, Takahiro
机构
来源
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP22-04
引用
收藏
页码:E296 / E297
页数:2
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy of invasive bladder cancer
    Isayeva, S. N.
    Selivanov, S. P.
    Udut, Ye. V.
    Kovalik, T. A.
    Shabunina, T. I.
    BYULLETEN SIBIRSKOY MEDITSINY, 2012, 11 (02): : 101 - +
  • [32] Neoadjuvant Chemotherapy for Invasive Bladder Cancer
    Guru Sonpavde
    Cora N. Sternberg
    Current Urology Reports, 2012, 13 : 136 - 146
  • [33] Neoadjuvant chemotherapy in invasive bladder cancer
    Bamias, Aristotle
    Dimopoulos, Meletios A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (06) : 993 - 1000
  • [34] Stool microbiota profiling of patients with muscle invasive bladder cancer receiving neoadjuvant pembrolizumab.
    Pederzoli, Filippo
    Locatelli, Irene
    Riba, Michela
    Bandini, Marco
    Raggi, Daniele
    Marandino, Laura
    Alchera, Elisa
    Giannatempo, Patrizia
    Provero, Paolo
    Lazarevic, Dejan
    Luciano, Roberta
    Gallina, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    Salonia, Andrea
    Necchi, Andrea
    Alfano, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Proteomic profiling of muscle invasive bladder cancer treated with neoadjuvant chemotherapy
    Contreras-Sanz, A.
    Reike, M. J.
    Negri, G.
    Htoo, Z. O.
    Miko, Spencer S.
    Nielsen, K.
    Roberts, M. E.
    Scurll, J.
    Ikeda, K.
    Wang, G.
    Seiler, R.
    Morin, G. B.
    Black, P. C.
    EUROPEAN UROLOGY, 2023, 83
  • [36] Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival
    Russell, Beth
    Sherif, Amir
    Haggstrom, Christel
    Josephs, Debra
    Kumar, Pardeep
    Malmstrom, Per-Uno
    Van Hemelrijck, Mieke
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 (04) : 206 - 212
  • [37] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [38] EFFECT OF NEOADJUVANT CHEMOTHERAPY ON THE IMMUNE MICROENVIRONMENT IN MUSCLE INVASIVE BLADDER CANCER
    Ikarashi, Daiki
    Kitano, Shigehisa
    Tsuyukubo, Takashi
    Kato, Yoichiro
    Nakatsura, Tetsuya
    Maekawa, Shigekatsu
    Kato, Renpei
    Obara, Wataru
    JOURNAL OF UROLOGY, 2021, 206 : E998 - E998
  • [39] Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Lyon, Timothy D.
    Frank, Igor
    Takahashi, Naoki
    Boorjian, Stephen A.
    Moynagh, Michael R.
    Shah, Paras H.
    Tarrell, Robert F.
    Cheville, John C.
    Viers, Boyd R.
    Tollefson, Matthew K.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 216 - +
  • [40] Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
    McFerrin, Coleman
    Davaro, Facundo
    May, Allison
    Raza, Syed
    Siddiqui, Sameer
    Hamilton, Zachary
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (06) : 565 - 572